Novel and Emerging Biomarkers with Risk Predictive Utility for Atherosclerotic Cardiovascular Disease

Nimish N. Shah, Anand Rohatgi

Research output: Contribution to journalReview article

Abstract

Purpose of Review: Since the release of the American Heart Association and American College of Cardiology’s 2013 pooled cohort equations and the European Cardiology Society’s 2016 SCORE, numerous studies have better characterized the predictive ability of emerging and novel biomarkers for atherosclerotic cardiovascular disease (ASCVD). Here, we review these emerging ASCVD biomarkers, with a focus on those that have been assessed using risk discrimination and reclassification performance indices in large population studies. Recent Findings: These biomarkers include genetic risk scores (GRS) based on a growing number of risk alleles, inflammatory and thrombotic markers, lipid components and functional measures, protein metabolites, microRNAs, and a variety of subclinical atherosclerosis imaging measures. While most of these markers have demonstrated some degree of association with and predictive utility for ASCVD, only coronary artery calcium (CAC) has demonstrated consistent risk prediction improvement across multiple population and risk profiles. Summary: Although CAC has garnered evidence to merit inclusion in modern risk prediction algorithms, large population studies and high-throughput genetic and protein technologies have shown promise for the risk prediction utility of several emerging biomarkers that may warrant consideration in future multimodality ASCVD risk prediction algorithms.

Original languageEnglish (US)
Article number7
JournalCurrent Cardiovascular Risk Reports
Volume12
Issue number3
DOIs
StatePublished - Mar 1 2018

Fingerprint

Cardiovascular Diseases
Biomarkers
Coronary Vessels
Population
Calcium
Cardiology
MicroRNAs
Atherosclerosis
Proteins
Alleles
Technology
Lipids

Keywords

  • ASCVD
  • Atherosclerosis
  • Biomarkers
  • Coronary artery calcium
  • Lipoproteins
  • Risk prediction

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Cite this

Novel and Emerging Biomarkers with Risk Predictive Utility for Atherosclerotic Cardiovascular Disease. / Shah, Nimish N.; Rohatgi, Anand.

In: Current Cardiovascular Risk Reports, Vol. 12, No. 3, 7, 01.03.2018.

Research output: Contribution to journalReview article

@article{810afb38a27b4e24924ab1dfb398f415,
title = "Novel and Emerging Biomarkers with Risk Predictive Utility for Atherosclerotic Cardiovascular Disease",
abstract = "Purpose of Review: Since the release of the American Heart Association and American College of Cardiology’s 2013 pooled cohort equations and the European Cardiology Society’s 2016 SCORE, numerous studies have better characterized the predictive ability of emerging and novel biomarkers for atherosclerotic cardiovascular disease (ASCVD). Here, we review these emerging ASCVD biomarkers, with a focus on those that have been assessed using risk discrimination and reclassification performance indices in large population studies. Recent Findings: These biomarkers include genetic risk scores (GRS) based on a growing number of risk alleles, inflammatory and thrombotic markers, lipid components and functional measures, protein metabolites, microRNAs, and a variety of subclinical atherosclerosis imaging measures. While most of these markers have demonstrated some degree of association with and predictive utility for ASCVD, only coronary artery calcium (CAC) has demonstrated consistent risk prediction improvement across multiple population and risk profiles. Summary: Although CAC has garnered evidence to merit inclusion in modern risk prediction algorithms, large population studies and high-throughput genetic and protein technologies have shown promise for the risk prediction utility of several emerging biomarkers that may warrant consideration in future multimodality ASCVD risk prediction algorithms.",
keywords = "ASCVD, Atherosclerosis, Biomarkers, Coronary artery calcium, Lipoproteins, Risk prediction",
author = "Shah, {Nimish N.} and Anand Rohatgi",
year = "2018",
month = "3",
day = "1",
doi = "10.1007/s12170-018-0570-0",
language = "English (US)",
volume = "12",
journal = "Current Cardiovascular Risk Reports",
issn = "1932-9520",
publisher = "Current Medicine Group",
number = "3",

}

TY - JOUR

T1 - Novel and Emerging Biomarkers with Risk Predictive Utility for Atherosclerotic Cardiovascular Disease

AU - Shah, Nimish N.

AU - Rohatgi, Anand

PY - 2018/3/1

Y1 - 2018/3/1

N2 - Purpose of Review: Since the release of the American Heart Association and American College of Cardiology’s 2013 pooled cohort equations and the European Cardiology Society’s 2016 SCORE, numerous studies have better characterized the predictive ability of emerging and novel biomarkers for atherosclerotic cardiovascular disease (ASCVD). Here, we review these emerging ASCVD biomarkers, with a focus on those that have been assessed using risk discrimination and reclassification performance indices in large population studies. Recent Findings: These biomarkers include genetic risk scores (GRS) based on a growing number of risk alleles, inflammatory and thrombotic markers, lipid components and functional measures, protein metabolites, microRNAs, and a variety of subclinical atherosclerosis imaging measures. While most of these markers have demonstrated some degree of association with and predictive utility for ASCVD, only coronary artery calcium (CAC) has demonstrated consistent risk prediction improvement across multiple population and risk profiles. Summary: Although CAC has garnered evidence to merit inclusion in modern risk prediction algorithms, large population studies and high-throughput genetic and protein technologies have shown promise for the risk prediction utility of several emerging biomarkers that may warrant consideration in future multimodality ASCVD risk prediction algorithms.

AB - Purpose of Review: Since the release of the American Heart Association and American College of Cardiology’s 2013 pooled cohort equations and the European Cardiology Society’s 2016 SCORE, numerous studies have better characterized the predictive ability of emerging and novel biomarkers for atherosclerotic cardiovascular disease (ASCVD). Here, we review these emerging ASCVD biomarkers, with a focus on those that have been assessed using risk discrimination and reclassification performance indices in large population studies. Recent Findings: These biomarkers include genetic risk scores (GRS) based on a growing number of risk alleles, inflammatory and thrombotic markers, lipid components and functional measures, protein metabolites, microRNAs, and a variety of subclinical atherosclerosis imaging measures. While most of these markers have demonstrated some degree of association with and predictive utility for ASCVD, only coronary artery calcium (CAC) has demonstrated consistent risk prediction improvement across multiple population and risk profiles. Summary: Although CAC has garnered evidence to merit inclusion in modern risk prediction algorithms, large population studies and high-throughput genetic and protein technologies have shown promise for the risk prediction utility of several emerging biomarkers that may warrant consideration in future multimodality ASCVD risk prediction algorithms.

KW - ASCVD

KW - Atherosclerosis

KW - Biomarkers

KW - Coronary artery calcium

KW - Lipoproteins

KW - Risk prediction

UR - http://www.scopus.com/inward/record.url?scp=85042749819&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042749819&partnerID=8YFLogxK

U2 - 10.1007/s12170-018-0570-0

DO - 10.1007/s12170-018-0570-0

M3 - Review article

VL - 12

JO - Current Cardiovascular Risk Reports

JF - Current Cardiovascular Risk Reports

SN - 1932-9520

IS - 3

M1 - 7

ER -